Publications by authors named "Tim Robinson"

Claim this Profile
C
CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.
Ki-Fong Man, Omeed Darweesh, Jinghui Hong, Alexandra Thompson, Charlotte O'Connor, Tim Robinson

Oncogene· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.
Ki-Fong Man, Omeed Darweesh, Jinghui Hong, Alexandra Thompson, Charlotte O'Connor, Tim Robinson

Oncogene· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK cancer vaccine advance - Recognising and realising opportunities.
Charles Craddock, Philip Earwaker, Matthew Fittall, Elisa Fontana, Divya Ganesh, Tim Robinson

Camb Prism Precis Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer.
Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, Jochen K Lennerz, Priyanka Sharma, Tim Robinson

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin.
Nancy My Teng, Andrea Malfettone, Matthew J Dalby, Raymond Kiu, David Seki, Tim Robinson, Stephen D Robinson

Microbiome Res Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.
Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D Yang, Tim Robinson

Br J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer.
Maximilian Marhold, Simon Udovica, Anna Halstead, Mona Hirdler, Muna Ferner, Tim Robinson

Oncoimmunology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Thomas Starkey, Maria C Ionescu, Michael Tilby, Martin Little, Emma Burke, Tim M Robinson

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically proxied impaired GIPR signaling and risk of 6 cancers.
Miranda Rogers, Dipender Gill, Emma Ahlqvist, Tim Robinson, Daniela Mariosa

iScience· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enriching Athlete-Environment Interactions in Youth Sport: The Role of a Department of Methodology.
Keith Davids, Martyn Rothwell, Sam Hydes, Tim Robinson, Charlie Davids

Children (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
Lennard Y W Lee, Michael Tilby, Thomas Starkey, Maria C Ionescu, Alex Burnett, Tim Robinson

JAMA Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Lennard Y W Lee, Maria C Ionescu, Thomas Starkey, Martin Little, Michael Tilby, Tim M Robinson

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lennard Y W Lee, Thomas Starkey, Maria C Ionescu, Martin Little, Michael Tilby, Tim M Robinson

Lancet Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective use of weight-based enoxaparin for deep vein thrombosis chemoprophylaxis in patients with traumatic brain injury.
Ashley Taylor, Patricia Martinez-Quinones, Ellen Huang, Tim Robinson, Cassandra Q White

Am J Surg· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis.
Nabila Kazmi, Tim Robinson, Jie Zheng, Siddhartha Kar, Richard M Martin

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
Ashley Taylor, Ellen Huang, Jennifer Waller, Cassandra White, Patricia Martinez-Quinones, Tim Robinson

Pharmacotherapy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Australian Economy in 2020-21: The COVID-19 Pandemic and Prospects for Economic Recovery.
Guay Lim, Viet Nguyen, Tim Robinson, Sarantis Tsiaplias, Jiao Wang

Aust Econ Rev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical methods for the determination of oil carryover from CNG/biomethane refueling stations recovered in a solvent.
Karine Arrhenius, Andreas Fischer, Oliver Büker, Hervé Adrien, Ahmad El Masri, Tim Robinson

RSC Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario" [Crit. Rev. Oncol./Hematol. 122 (February) (2018) 150-156].
Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello

Crit Rev Oncol Hematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario.
Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello

Crit Rev Oncol Hematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of noise-induced hearing loss among woodworkers in Nepal: a pilot study.
Tim Robinson, Joshua Whittaker, Aanand Acharya, Devesh Singh, Michael Smith

Int J Occup Environ Health· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
Anna Kuchel, Tim Robinson, Charles Comins, Mike Shere, Mohini Varughese

Br J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from an elective in Sierra Leone.
Tim Robinson

Pan Afr Med J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smartphone use and acceptability among clinical medical students: a questionnaire-based study.
Tim Robinson, Thomas Cronin, Haider Ibrahim, Mark Jinks, Timothy Molitor

J Med Syst· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A winning formula for new laboratories.
Tim Robinson

Health Estate· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis